These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1592885)

  • 21. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercalcemic complication in patients with oral squamous cell carcinoma.
    Iwase M; Takemi T; Manabe M; Nagumo M
    Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery of serum calcium concentrations following acute hypocalcemia in patients with osteoporosis on long-term oral therapy with the bisphosphonate pamidronate.
    Landman JO; Schweitzer DH; Frölich M; Hamdy NA; Papapoulos SE
    J Clin Endocrinol Metab; 1995 Feb; 80(2):524-8. PubMed ID: 7852514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.
    Khosla S; Ebeling PR; Firek AF; Burritt MM; Kao PC; Heath H
    J Clin Endocrinol Metab; 1993 Mar; 76(3):715-20. PubMed ID: 8445032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen replacement decreases the set point of parathyroid hormone stimulation by calcium in normal postmenopausal women.
    Boucher A; D'Amour P; Hamel L; Fugère P; Gascon-Barré M; Lepage R; Ste-Marie LG
    J Clin Endocrinol Metab; 1989 Apr; 68(4):831-6. PubMed ID: 2921312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations.
    Hove K; Horst RL; Littledike ET; Beitz DC
    Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gestational hypercalcemia: Prevalence and biochemical profile.
    Schoenmakers I; Piec I; Baban S; Bärebring L; Green D; Washbourne CJ; Tang JCY; Fraser WD; Augustin H
    J Steroid Biochem Mol Biol; 2020 May; 199():105611. PubMed ID: 32007562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blunted parathyroid response to correction of hypercalcemia in subjects with squamous cell carcinoma.
    Yap AS; Mortimer RH; Jacobi JM; Galligan JP; Perry-Keene DA; Khafagi FA
    Horm Res; 1993; 40(5-6):222-6. PubMed ID: 8112724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
    Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
    Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
    Rajala MM; Klee GG; Heath H
    J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma PTH and PTH-rP levels and clodronate therapy in cancer patients with hypercalcemia.
    Su RJ; Chang CC; Tsai KS
    J Formos Med Assoc; 1993 Nov; 92(11):977-82. PubMed ID: 7910069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian variation of the Ca2+ -PTH curve during hypercalcaemia in dogs.
    Domingo V; López I; Mendoza FJ; Rodríguez M; Aguilera-Tejero E; Estepa JC
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):545-8. PubMed ID: 18045336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions.
    Brossard JH; Whittom S; Lepage R; D'Amour P
    J Clin Endocrinol Metab; 1993 Aug; 77(2):413-9. PubMed ID: 8345045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
    Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
    World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
    Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.